Interviews, Articles & Podcasts
OIS: Ophthalmology Innovation Source
The Future Outlook of Dry AMD: One Disease or Many?
December 2, 2025
How Lineage Cell Therapeutics Is Advancing Regenerative Medicine Through Cell Replacement
October 30, 2025
Lineage Nabs $12M Demant Partnership: Cell Therapy Treatment Could Address Hearing Loss
September 08, 2025
Retinal Physician
Article: Trial Data Indicates Cell Therapy May Reverse GA Damage. Surgical delivery of OpRegen RPE cell therapy produced sustained anatomical and functional improvements in geographic atrophy, according to 36-month data.
June 30, 2025
Labiotech
CEO Brian Culley joins the podcast to discuss treating spinal cord injuries with stem cells.
March 28, 2025
January 24, 2025
Presentations from specific events, conferences, or showcases
Key opinion leaders discuss topics related to Lineage’s clinical programs
Richard Fessler, MD, Professor of Neurosurgery, Rush University Medical School, discusses data seen in the phase 1/2 clinical trial of OPC1 for spinal cord injury (watch on CGTLive.com)
July 20, 2022
Review of the pathogenesis of AMD and the pathways to CNV and GA
Jordi Monés, M.D., Ph.D., Director, Institut de la Màcula and Director, Principal Investigator and Founder, Barcelona Macula Foundation
OpRegen® Phase 1/2a Clinical Study Results
2020 ARVO Meeting
Christopher D. Riemann, M.D., Cincinnati Eye Institute (CEI)
Why is dry age-related macular degeneration (dry AMD) research so important?
Allen C. Ho, M.D., Wills Eye Hospital Director of Retina Research
Why is spinal cord research so important?
Dr. John Steeves, Emeritus Principal Investigator @ICORD and Professor @UBC
A selection of patient focused media related to our cell therapy programs
January 24, 2025
The Stem Cellar
The Official Blog of CIRM, California’s Stem Cell Agency
Where Are They Now: Jake Javier
Pioneering Cell Transplants for the Treatment of Spinal Cord Injury
Christopher and Dana Reeve Foundation Blog
OPC1 Patient Spotlight – Chris Block – Part 1
In 2016, Chris Block was paralyzed in a bicycling accident. In 2023, he is an avid scuba diver, horseback rider and, importantly, has his independence.
OPC1 Patient Spotlight – Chris Block – Part 2
In 2016, Chris Block was paralyzed in a bicycling accident. In 2023, he is an avid scuba diver, horseback rider and, importantly, has his independence.
The Stem Cellar
The Official Blog of CIRM, California’s Stem Cell Agency
Update on spinal cord injury patient Jake Javier, enrolled in CIRM-funded stem cell clinical trial
OPC1 Program – Patient Spotlight – Jake Javier
In 2016, Jake Javier was paralyzed from the neck down. In late 2022, he is set to graduate from Duke University with his Master’s Degree in Biomedical Engineering, with plans to help those impacted by neurological injuries or diseases.
Sonia Cohen’s OpRegen Story
OpRegen for Dry AMD | Lineage Cell Therapeutics
Cheri’s Story
OpRegen for Dry AMD | Lineage Cell Therapeutics
WDAM7 Mississippi
“New Treatment for Age-Related Dry Macular Degeneration”
5 years through the eyes of a mum.
A powerful dramatization of living with the progression of vision loss related to AMD. Source: www.macularsociety.org
Spinal Cord Injury and Lineage’s OPC1 Cell Therapy
An instructive whiteboard video explaining how spinal cord injury disrupts normal bodily function as well as OPC1 administration and mechanism of action.
OPC1 Program – Patient Spotlight – Kris Boesen and Lucas Lindner
Highlighting the progress made by Kris Boesen and Lucas Lindner, both of whom received Lineage’s OPC1 cell therapy following traumatic spinal cord injury (SCI).
Lucas Lindner was paralyzed from the neck down following a car accident. The next year, he threw out the first pitch at a Major League Baseball game.
Watch the video above to learn more about Lucas’ journey.